BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 26164540)

  • 21. Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study.
    Azab SF; Akeel NE; Abdalhady MA; Elhewala AA; Ali ASA; Amin EK; Sarhan DT; Almalky MAA; Elhindawy EM; Salam MMA; Soliman AA; Abdellatif SH; Ismail SM; Elsamad NA; Hashem MIA; Aziz KA; Elazouni OMA; Arafat MS
    Medicine (Baltimore); 2016 Mar; 95(9):e2921. PubMed ID: 26945394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepcidin and iron deficiency in pre-kidney transplant patients.
    Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
    Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study.
    Cherry-Bukowiec JR; Engoren M; Wiktor A; Raghavendran K; Napolitano LM
    Crit Care Med; 2018 Jun; 46(6):e567-e574. PubMed ID: 29517550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
    da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
    J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Running a 100-km ultra-marathon induces an inflammatory response but does not raise the level of the plasma iron-regulatory protein hepcidin.
    Kasprowicz K; Ziemann E; Ratkowski W; Laskowski R; Kaczor JJ; Dadci R; Antosiewicz J
    J Sports Med Phys Fitness; 2013 Oct; 53(5):533-7. PubMed ID: 23903534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.
    Brătescu LO; Bârsan L; Gârneaţă L; Stanciu A; Lipan M; Stancu SH; Mircescu G
    Int Urol Nephrol; 2014 May; 46(5):1005-12. PubMed ID: 24800994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
    Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
    Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia.
    Przybyszewska J; Żekanowska E; Kędziora-Kornatowska K; Boinska J; Cichon R; Porzych K
    Pol Arch Med Wewn; 2013; 123(3):105-11. PubMed ID: 23299925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin as a potential biomarker for blood doping.
    Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
    Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
    Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.
    Enko D; Wagner H; Kriegshäuser G; Kimbacher C; Stolba R; Worf E; Halwachs-Baumann G
    Eur J Haematol; 2015 Dec; 95(6):507-13. PubMed ID: 25598480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study.
    van Santen S; Kroot JJ; Zijderveld G; Wiegerinck ET; Spaanderman ME; Swinkels DW
    Clin Chem Lab Med; 2013 Jul; 51(7):1395-401. PubMed ID: 23241678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.
    Eleftheriadis T; Pissas G; Remoundou M; Filippidis G; Antoniadi G; Oustampasidou N; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2014 Jan; 46(1):161-7. PubMed ID: 23860963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
    Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
    Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
    Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
    Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.